← Leaderboards
Charles J Lowenstein
Johns Hopkins University
$14,170,963
Attributed
$18,691,979
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,691,979 · 13
By mechanism
R01$8,142,183 · 5
P01$5,127,133 · 3
R33$1,967,631 · 1
R61$1,372,686 · 1
T32$1,279,541 · 1
R21$419,055 · 1
Top collaborators
- Nicholas L Smith9 shared
- Alisa S Wolberg5 shared
- William Owen Osburn2 shared
- Craig N Morrell1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- William M Baldwin$16,703,281
- Shruti Chaturvedi$1,745,723
- Diane E Griffin$24,000,430
- Zhaoli Sun$13,175,173
- Barbara A Wasowska$1,309,000
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxidePathway InteractionsMolecularThrombosisLaboratory MouseProteinsInflammationEndothelial CellsExocytosisNitric Oxide SynthaseBiologicalMediatingPlayVon Willebrand FactorSignal TransductionIn VitroGeneticVascular InflammationGenetic TranscriptionCytoplasmic GranulesInjuryCandidate Disease GeneGenesCells
Grant awards (43)
BCOR Regulation of Venous Thromboembolism$666,710
R01 · FY2025 · HL · contact PI
BCOR Regulation of Venous Thromboembolism$666,710
R01 · FY2024 · HL · contact PI
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology$626,843
R33 · FY2022 · HL · contact PI
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology$667,852
R33 · FY2021 · HL · contact PI
Population genomic variation, functional biology, and the risk of venous thrombosis$708,902
R01 · FY2020 · HL
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology$672,936
R33 · FY2020 · HL · contact PI
Population genomic variation, functional biology, and the risk of venous thrombosis$710,830
R01 · FY2019 · HL
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology$672,507
R61 · FY2019 · HL · contact PI
Population genomic variation, functional biology, and the risk of venous thrombosis$714,467
R01 · FY2018 · HL
Model system of oral contraceptive-induced VTE: integrating genomic, transcriptomic, and proteomic discovery with functional biology$700,179
R61 · FY2018 · HL · contact PI
Population genomic variation, functional biology, and the risk of venous thrombosis$736,908
R01 · FY2017 · HL
Research Training in Preventive Cardiology$635,619
T32 · FY2014 · HL · contact PI
VAMP8 regulates endothelial exocytosis and microvascular obstruction$383,750
R56 · FY2014 · HL · contact PI
Novel Regulators of Endothelial Exocytosis$150,430
R21 · FY2014 · HL · contact PI
Research Training in Preventive Cardiology$643,922
T32 · FY2013 · HL · contact PI
Novel Regulators of Endothelial Exocytosis$268,625
R21 · FY2013 · HL · contact PI
Regulation of Exocytosis in the Post-Ischemic Myocardium$392,466
P01 · FY2010 · HL · contact PI
Regulation of Exocytosis in the Post-Ischemic Myocardium$383,322
P01 · FY2009 · HL · contact PI
Regulation of Exocytosis in the Post-Ischemic Myocardium$369,584
P01 · FY2008 · HL · contact PI
Regulation of Exocytosis in the Post-Ischemic Myocardium$437,382
P01 · FY2007 · HL · contact PI
Regulation of Weibel-Palade Body Secretion in Accelerated Graft Arteriosclerosis$350,214
P01 · FY2007 · HL · contact PI
Exocytosis and Vascular Inflammation$310,055
R01 · FY2007 · HL · contact PI
Regulation of Vascular Inflammation$310,055
R01 · FY2007 · HL · contact PI
Regulation of Vascular Inflammation$51,952
R01 · FY2007 · HL · contact PI
Regulation of Exocytosis in the Post-Ischemic Myocardium$408,438
P01 · FY2006 · HL · contact PI
Exocytosis and Vascular Inflammation$319,316
R01 · FY2006 · HL · contact PI
Regulation of Vascular Inflammation$319,316
R01 · FY2006 · HL · contact PI
Exocytosis and Vascular Inflammation$327,000
R01 · FY2005 · HL
Regulation of Vascular Inflammation$245,250
R01 · FY2005 · HL
Regulation of Vascular Inflammation$408,750
R01 · FY2004 · HL
Exocytosis and Vascular Inflammation$327,000
R01 · FY2004 · HL
Regulation of Weibel-Palade Body Secretion in AGA$348,311
P01 · FY2003 · HL
REGULATION OF NOS2 IN ISCHEMIC MYOCARDIUM$344,145
R01 · FY2003 · HL
Regulating NOS2 in ischemic &post-ischemic myocardium$297,097
P01 · FY2003 · HL
MEDIATORS OF ACCELERATED GRAFT ARTERIOSCLEROSIS$498,057
P01 · FY2002 · HL
REGULATION OF NOS2 IN ISCHEMIC MYOCARDIUM$334,118
R01 · FY2002 · HL
Regulating NOS2 in ischemic &post-ischemic myocardium$297,097
P01 · FY2002 · HL
MEDIATORS OF ACCELERATED GRAFT ARTERIOSCLEROSIS$498,057
P01 · FY2001 · HL
REGULATION OF NOS2 IN ISCHEMIC MYOCARDIUM$324,799
R01 · FY2001 · HL
Regulating NOS2 in ischemic &post-ischemic myocardium$297,097
P01 · FY2001 · HL
REGULATION OF NOS2 IN ISCHEMIC MYOCARDIUM$315,900
R01 · FY2000 · HL
Regulating NOS2 in ischemic &post-ischemic myocardium$297,097
P01 · FY2000 · HL
MEDIATORS OF ACCELERATED GRAFT ARTERIOSCLEROSIS$252,914
P01 · FY2000 · HL